Cefdinir Capsule
NDC Package 82868-059-20

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Cefdinir capsules is cefdinir is used to treat a wide variety of bacterial infections. This formulation utilizes a capsule delivery system. Marketed by Northwind Health Company, Llc, this product is identified by NDC 82868-059 and is authorized under FDA application ANDA210220.

Identification & Billing

NDC Package Code
82868-059-20
Package Description
20 CAPSULE in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
82868005920
RxNorm Crosswalk
RxCUI: 200346 - cefdinir 300 MG Oral Capsule

Clinical Specifications

Proprietary Name
Cefdinir
Non-Proprietary Name
Cefdinir
Substance Name
Cefdinir
Dosage Form
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Cefdinir is used to treat a wide variety of bacterial infections. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Regulatory & Marketing

Labeler Name
Northwind Health Company, Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA210220
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-25-2024
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 82868-059-20 identifies a specific commercial package of 20 capsule in 1 bottle, plastic of Cefdinir, a human prescription drug labeled by Northwind Health Company, Llc. This capsule is formulated for oral use and contains cefdinir as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Northwind Health Company, Llc on June 25, 2024. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

Cefdinir is used to treat a wide variety of bacterial infections. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

How is this Northwind Health Company, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 82868005920. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
82868-059-20
11-Digit CMS (5-4-2)
82868-0059-20

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.